Cash and Cash Equivalents, at Carrying Value in USD of SQZ Biotechnologies Co from Q4 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
SQZ Biotechnologies Co quarterly Cash and Cash Equivalents, at Carrying Value history and change rate from Q4 2019 to Q3 2023.
  • SQZ Biotechnologies Co Cash and Cash Equivalents, at Carrying Value for the quarter ending 30 Sep 2023 was $10.2M, a 87.9% decline year-over-year.
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

SQZ Biotechnologies Co Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2023 $10.2M -$74M -87.9% 30 Sep 2023 10-Q 08 Nov 2023
Q2 2023 $24.7M -$80.9M -76.6% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $39.9M -$83M -67.6% 31 Mar 2023 10-Q 10 May 2023
Q4 2022 $63.7M -$79.8M -55.6% 31 Dec 2022 10-Q 08 Nov 2023
Q3 2022 $84.2M -$80M -48.7% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $106M -$79.5M -43% 30 Jun 2022 10-Q 04 Aug 2022
Q1 2022 $123M -$82M -40% 31 Mar 2022 10-Q 10 May 2022
Q4 2021 $144M -$26.8M -15.8% 31 Dec 2021 10-K 22 Mar 2023
Q3 2021 $164M +$57.2M +53.4% 30 Sep 2021 10-Q 10 Nov 2021
Q2 2021 $185M 30 Jun 2021 10-Q 04 Aug 2021
Q1 2021 $205M 31 Mar 2021 10-Q 11 May 2021
Q4 2020 $170M +$131M +334% 31 Dec 2020 10-K 16 Mar 2022
Q3 2020 $107M 30 Sep 2020 10-Q 10 Dec 2020
Q4 2019 $39.3M 31 Dec 2019 10-K 18 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.